Prostatype Genomics enters the Italian market
Prostatype Genomics can announce a new cooperation that opens up the Italian market for the Prostate cancer test Prostatype®. The initiative will be led by Maurizio Ballerini MD and is already operational.Dr. Maurizio Ballerini comments: “I am happy and proud to be able to represent Prostatype Genomics and Prostatype® in Italy. Prostatype® is an innovative and advanced prostate cancer biomarker that will perfectly match the strategy of providing leading products within the prognostic/therapeutic field in Italy. Representing Prostatype® will create great opportunities to get access to